Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China · Delayed Price · Currency is CNY 8.53
+0.43 (5.31%)
Sep 14, 2026, 3:00 PM CST
SHA:600613 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,043 | 3,098 | 3,515 | 3,902 | 4,220 | 3,291 | |
Market Cap Growth | 17.25% | -11.88% | -9.91% | -7.55% | 28.22% | 31.69% |
Enterprise Value | 3,471 | 2,546 | 2,951 | 3,492 | 4,021 | 3,173 |
Last Close Price | 8.10 | 5.98 | 6.61 | 7.20 | 7.67 | 5.88 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 161.85 | 80.99 | 49.24 | 68.45 | 86.93 | 47.28 |
PS Ratio | 2.20 | 1.59 | 1.72 | 1.67 | 1.77 | 1.43 |
PB Ratio | 1.70 | 1.29 | 1.45 | 1.63 | 1.78 | 1.38 |
P/TBV Ratio | 2.06 | 1.56 | 1.74 | 1.96 | 2.19 | 1.70 |
P/FCF Ratio | 26.24 | 33.94 | 20.51 | 20.42 | 14.43 | 33.48 |
P/OCF Ratio | 23.05 | 24.89 | 16.92 | 18.10 | 13.22 | 17.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.89 | 1.30 | 1.44 | 1.49 | 1.68 | 1.38 |
EV/EBITDA Ratio | 22.28 | 17.69 | 17.17 | 16.83 | 23.57 | 21.55 |
EV/EBIT Ratio | 49.32 | 36.56 | 31.59 | 27.64 | 46.87 | 34.99 |
EV/FCF Ratio | 22.53 | 27.90 | 17.22 | 18.28 | 13.74 | 32.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.09 | 0.09 | 0.11 | 0.12 | 0.13 |
Debt / EBITDA Ratio | 0.36 | 1.34 | 1.17 | 1.15 | 1.57 | 1.99 |
Debt / FCF Ratio | 0.36 | 2.30 | 1.27 | 1.32 | 0.98 | 3.18 |
Net Debt / Equity Ratio | -0.28 | -0.24 | -0.24 | -0.20 | -0.16 | -0.08 |
Net Debt / EBITDA Ratio | -4.33 | -4.00 | -3.39 | -2.33 | -2.17 | -1.23 |
Net Debt / FCF Ratio | -4.24 | -6.31 | -3.40 | -2.53 | -1.27 | -1.85 |
Asset Turnover | 0.62 | 0.62 | 0.64 | 0.70 | 0.73 | 0.74 |
Inventory Turnover | 5.07 | 5.11 | 4.66 | 5.15 | 5.31 | 4.49 |
Quick Ratio | 2.47 | 2.31 | 2.51 | 2.18 | 1.91 | 2.48 |
Current Ratio | 2.94 | 2.66 | 3.01 | 2.58 | 2.29 | 3.01 |
Return on Equity (ROE) | 1.30% | 1.65% | 2.74% | 2.45% | 2.03% | 2.88% |
Return on Assets (ROA) | 1.49% | 1.39% | 1.83% | 2.37% | 1.64% | 1.81% |
Return on Invested Capital (ROIC) | 1.99% | 2.14% | 3.76% | 4.52% | 3.11% | 2.85% |
Return on Capital Employed (ROCE) | 2.90% | 2.80% | 3.60% | 4.90% | 3.30% | 3.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.68% | 1.23% | 2.03% | 1.46% | 1.15% | 2.11% |
FCF Yield | 3.81% | 2.95% | 4.88% | 4.90% | 6.93% | 2.99% |
Dividend Yield | 0.78% | 1.17% | 2.27% | 1.39% | 1.30% | 1.70% |
Payout Ratio | 155.58% | 230.69% | 89.91% | 116.30% | 142.06% | 5.70% |
Buyback Yield / Dilution | 0.86% | 0.51% | -5.97% | 3.94% | -0.72% | -0.46% |
Total Shareholder Return | 1.64% | 1.68% | -3.70% | 5.33% | 0.58% | 1.24% |